ETON News and Press, Eton Pharmaceutcials Inc. From 03/08/22

DEER PARK, Ill., March 08, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report fourth quarter 2021 financial results on Wednesday, ...

AAP, ACTG, AESE, OTCPK:AOIFF, DADAASTS, ATHX, AXON, AYTU, BIOC, BITF, CIDM, CMP, OTCQX:CWBHF, CWBR, CWCO, CYBN, DM, DNMR, DRIO, OTCQB:ELTP, ETON, EVFM, GLAD, GNLN, GOEV, IBIO, IDEX, INPX, IONQ, ISUN, LCID, LUNA, MARK, OTCQX:MRMD, MVST, NDRA, NEPT, PLBY, POWW, PRCH, PRPO, QFIN, RKDA,...

Product is now available exclusively through Anovo specialty pharmacy Product is stable at room temperature while Carbaglu® requires refrigeration Eton Cares patient support program will offer $0 co-pays to commercial insurance patients DEER PARK, Ill., Dec. 20, 2021 ...

Check These Biotech Penny Stocks Out For Your Watchlist Right Now Finding the best biotech penny stocks to buy is all about understanding what catalysts are on the horizon. While most penny stocks are speculative, and therefore trade heavily on news and events, biotech stocks are es...

LONDON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a neuropharmaceutical company focused on psychedelic-assisted therapies, announces that Mr. Paul Maier has been appointed as a no...

The following slide deck was published by Eton Pharmaceuticals, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Eton Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call Presentation

Eton Pharmaceuticals (ETON) Q3 2021 Earnings Conference Call November 15, 2021 4:30 PM ET Company Participants David Krempa – Senior Vice President-Business Development and Investor Relations Sean Brynjelsen – Chief Executive Officer Wilson Troutman – Chief Financial Offi...

Eton Pharmaceuticals (NASDAQ:ETON): Q3 GAAP EPS of -$0.24 misses by $0.10. Revenue of $0.78M misses by $2.26M. Shares -5%. Press Release Cash and cash equivalents were $22.7 million as of September 30, 2021. For further details see: Eton Pharmaceuticals EPS misses by $0.10, misses on re...

DEER PARK, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the third quarter ended September 30, 2021. ...

Eton Pharmaceuticals (NASDAQ:ETON) has added ~4.6% in the pre-market after announcing a multi-year agreement with Tolmar Pharmaceuticals to co-promote ALKINDI SPRINKLE, an FDA-approved replacement therapy for Adrenocortical Insufficiency (AI) in children. Tolmar currently promo...